Skip to main content
Premium Trial:

Request an Annual Quote

System Biosciences Taps Maverix's Platform for Exosome Sequence Analytics Service

Premium

System Biosciences has selected Maverix Biomics' bioinformatics platform to provide the data analysis component of its company's newly launched exosome RNA sequence analytics service, dubbed Exo-NGS.

Under the terms of the arrangement, customers of SBI's service will be able to use Maverix's cloud-based next generation sequence data management, exploration, and visualization platform (BI 11/9/2012) to identify and analyze exosome-associated RNA biomarkers.

The cloud solution includes features such as library sequence quality control metrics, tools for relative RNA abundance and identity analysis, differential expression analysis, and data visualization capabilities such as RNA type charts, expression heatmaps. Users also have access to resources such as the ENCODE data which allows them to explore their data in the context of public datasets.

The financial terms of the agreement are not being disclosed.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.